Danshen injection induces autophagy in podocytes to alleviate nephrotic syndrome via the PI3K/AKT/mTOR pathway
Authors:
- 25 September 2022
- journal article
- research article
- Published by Elsevier in Phytomedicine
- Vol. 107, 154477
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82174061)
This publication has 26 references indexed in Scilit:
- Safety, Tolerability, and Management of Toxic Effects of Phosphatidylinositol 3-Kinase Inhibitor Treatment in Patients With CancerJAMA Oncology, 2019
- Cryptotanshinone ameliorates renal ischaemia–reperfusion injury by inhibiting apoptosis and inflammatory responseBasic & Clinical Pharmacology & Toxicology, 2019
- Preclinical Absorption, Distribution, Metabolism, and Excretion of Sodium Danshensu, One of the Main Water-Soluble Ingredients in Salvia miltiorrhiza, in RatsFrontiers in Pharmacology, 2019
- Increased autophagy is cytoprotective against podocyte injury induced by antibody and interferon-α in lupus nephritisAnnals of the Rheumatic Diseases, 2018
- Long noncoding RNA HULC accelerates liver cancer by inhibiting PTEN via autophagy cooperation to miR15aMolecular Cancer, 2018
- Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signalingNature Communications, 2017
- Danshen injection prevents heart failure by attenuating post-infarct remodelingJournal of Ethnopharmacology, 2017
- Danshen injection ameliorates STZ-induced diabetic nephropathy in association with suppression of oxidative stress, pro-inflammatory factors and fibrosisInternational Immunopharmacology, 2016
- Renoprotection of Danshen Injection on streptozotocin-induced diabetic rats, associated with tubular function and structureJournal of Ethnopharmacology, 2014
- High incidence of initial and late steroid resistance in childhood nephrotic syndromeKidney International, 2005